I a new study from @matslassen et al in @CircAHA they found that there was a greater risk of thromboembolic events after infection with SARS-CoV-2 than with the mRNA vaccine @politiken link (Danish newspaper) https://t.co/eb7yHYigHN Circulation link https://t.co/L7pqRcRKin

Lower baroreflex sensitivity was associated with lower SpO2 in type 1 diabetes. This support the hypothesis that hypoxia could be a therapeutic target in persons with type 1 diabetes. @Stenodiabetes @FinnDianeStudy @JensChristianL2 https://t.co/rL1ZC53m2S

Is lactate really a ’phoenix risen’ that drives numerous beneficial effects of exercise? Our new study in @NatMetabolism reveals major methodological flaws that affect studies of sodium lactate and potentially also other metabolite salts. Thread 👇 1/16 https://t.co/NP2xslQlHi

What is the kidney effect of diabetes and the diabetogenic TBC1D4 p.Arg684ter variant on in Inuit in Greenland ? see this great work from @OvervadMaria https://t.co/ekHe9S8lyT @Stenodiabetes

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes @FrederikPersson, @DorteVistisen, @P_Rossing https://t.co/hENSOyZoC4

Can oral ketone esters improve cardiac function? Find out by reading Helena's new interesting paper on the effect of oral ketone esters on myocardial contractility in persons previously admitted with Covid-19: https://t.co/wLhPM8SSp8 @Stenodiabetes

Dear all, Our paper “Lower Blood Oxygen Saturation is Associated With Microvascular Complications in Individuals With Type 1 Diabetes” has been selected as JCEM’s Featured Article this week. Read it here: https://t.co/2EKPA97ONV @Stenodiabetes @P_Rossing @ChristianStevns

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidocis https://t.co/wY0QOVooiH @Stenodiabetes @FrederikPersson

See the RCT demonstrating the benefit of flexor Tendon Tenotomy Treatment of the Diabetic Foot for healing of ulcer and prevention: https://t.co/wyIcPMAVj7 R @Stenodiabetes

Lower blood oxygen saturation is associated with microvascular complications in a large group with T1D maybe a new treatment target? https://t.co/Yswcnui3S9 @JensChristianL2 @Stenodiabetes

@JensChristianL2 presents importance of hypoxia for Micro and macrovascular complications In diabetes #EASD2022 @Stenodiabetes

At #EASD2022 Jens Laursen from @Stenodiabetes showing an association between hypoxia and microvascular complications in #T1D

Did you know that increased glucose variability is associated with cardiovascular autonomic neuropathy in Type 1 Diabetes? See Sara's interesting paper here: https://t.co/CGQCFgPzxL @ChristianStevns @P_Rossing @Stenodiabetes @DiabetesCareADA

Sara Naaman (medical student) with @ChristianStevns @Stenodiabetes concludes that Cardiovascular Autonomic Neuropathy Is Associated With Increased Glucose Variability in People With Type 1 Diabetes

Delighted this is out, #metabolomics #lipidomics for #precisionmedicine in Type 1 #diabetes, looking at molecules to find ways of preventing future cardiovascular complications. Led by @LFelipeFDivino & @TommiSuvitaival #OA in @BioMedCentral URL link: https://t.co/pChtlRdq4E

Exciting new research from @LFelipeFDivino and @TommiSuvitaival ! Several circulating metabolites are associated with development of cardiovascular events in type 1 diabetes! Paving the way for metabolomics in diabetes! https://t.co/ZefkzkkRbL @DrLegidoQuigley @P_Rossing

Did you know that kidney oxygenation is associated with albuminuria and eGFR in type 1 diabetes? See our paper here: https://t.co/n0351flCOZ @Stenodiabetes @Rigshospitalet @P_Rossing @PBjornstadMD @CKJsocial

Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type ...

Post doc eller videnskabelig assistent https://t.co/zA6P2vkRqu Er det dig, vi skal ansætte? Kom frisk med en ansøgning, hvis du interesserer dig for forskning i personcentreret diabetesbehandling.

Although SUPAR is a terrific marker, Acute and Long-Term Treatment With Dapagliflozin has no impact on Serum Soluble Urokinase Plasminogen Activator Receptor in this study https://t.co/MJ1XyIsHLt @Stenodiabetes @jespereugen